 |
PDBsum entry 5l1h
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transport protein/inhibitor
|
PDB id
|
|
|
|
5l1h
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transport protein/inhibitor
|
 |
|
Title:
|
 |
Ampa subtype ionotropic glutamate receptor glua2 in complex with noncompetitive inhibitor gyki53655
|
|
Structure:
|
 |
Glutamate receptor 2. Chain: a, b, c, d. Fragment: unp residues 25-847, with deletions of 397-398, 402-405, 566-587. Synonym: glur-2,ampa-selective glutamate receptor 2,glur-b,glur-k2, glutamate receptor ionotropic,ampa 2,glua2. Engineered: yes
|
|
Source:
|
 |
Rattus norvegicus. Rat. Organism_taxid: 10116. Gene: gria2, glur2. Expressed in: homo sapiens. Expression_system_taxid: 9606. Expression_system_cell_line: hek293 gnti.
|
|
Resolution:
|
 |
|
3.80Å
|
R-factor:
|
0.277
|
R-free:
|
0.292
|
|
|
Authors:
|
 |
M.V.Yelshanskaya,A.K.Singh,J.M.Sampson,A.I.Sobolevsky
|
|
Key ref:
|
 |
M.V.Yelshanskaya
et al.
(2016).
Structural Bases of Noncompetitive Inhibition of AMPA-Subtype Ionotropic Glutamate Receptors by Antiepileptic Drugs.
Neuron,
91,
1305-1315.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
29-Jul-16
|
Release date:
|
19-Oct-16
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P19491
(GRIA2_RAT) -
Glutamate receptor 2 from Rattus norvegicus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
883 a.a.
773 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
|
*
PDB and UniProt seqs differ
at 12 residue positions (black
crosses)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Neuron
91:1305-1315
(2016)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural Bases of Noncompetitive Inhibition of AMPA-Subtype Ionotropic Glutamate Receptors by Antiepileptic Drugs.
|
|
M.V.Yelshanskaya,
A.K.Singh,
J.M.Sampson,
C.Narangoda,
M.Kurnikova,
A.I.Sobolevsky.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Excitatory neurotransmission plays a key role in epileptogenesis.
Correspondingly, AMPA-subtype ionotropic glutamate receptors, which mediate
the majority of excitatory neurotransmission and contribute to seizure
generation and spread, have emerged as promising targets for epilepsy therapy.
The most potent and well-tolerated AMPA receptor inhibitors act via a
noncompetitive mechanism, but many of them produce adverse side effects. The
design of better drugs is hampered by the lack of a structural understanding of
noncompetitive inhibition. Here, we report crystal structures of the rat
AMPA-subtype GluA2 receptor in complex with three noncompetitive inhibitors. The
inhibitors bind to a novel binding site, completely conserved between rat and
human, at the interface between the ion channel and linkers connecting it to the
ligand-binding domains. We propose that the inhibitors stabilize the AMPA
receptor closed state by acting as wedges between the transmembrane segments,
thereby preventing gating rearrangements that are necessary for ion channel
opening.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |